AKT1 and cancer: This study reported for the first time that CK2 down-regulation in human cancer cells enhances the expression of SASP factors (IL-1β, IL-6, and MMP3) by NF-κB activation through two pathways: an SIRT1-dependent/AKT-independent pathway and an SIRT1/AKT-dependent pathway.